Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
InChiKey: PCCVCJAQMHDWJY-UHFFFAOYSA-N
24 hours) reduces the expression of GPX4 protein
Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011
cell-permeable and selective spastin (a microtubule-severing AAA (ATPases associated with diverse cellular activities) protein) inhibitor with IC50 of 99 nM for Human spastin
7-Chlorokynurenic acid sodium salt Size:Contact [email protected] for quotation InChiKey: PCCVCJAQMHDWJY-UHFFFAOYSA-N7 Chlorokynurenic acid sodium salt (7 CKA sodium salt) is a potent and selective antagonist of the glycine B coagonist site of the N methyl D aspartate (NMDA) receptor (IC50=0. 56 M). 7 Chlorokynurenic acid sodium salt is also a potent inhibitor of the reuptake of glutamate into synaptic vesicles with a Ki of 0. 59 M. 7 Chlorokynurenic acid sodium salt has potent antinociceptive actions after neuraxial delivery. Product information CAS Number: 1263094
US$ 3749.50
US$ 158.00
US$ 16.99
US$ 50.00
US$ 3499.50
US$ 16.99
US$ 16.99
US$ 158.00
US$ 50.00
US$ 16.99
US$ 15.00